4COHEN S, SHOSttANA O Y, ZELMAN-TOISTER E, et al. The cytokine midkine and its receptor RPTP regulate B cell survival in a pathway induced by CD74[J]. J Immunol, 2012,188(1) : 259-269.
5MITCHELL R A, LIAO H, CHESNEY J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proin- flammatory function by inhibiting p53: regulatory role in the innate immune response[J]. Proc Natl Acad Sci U S A, 2002, 99(1) :345-350.
6RONQUIST G, NILSSON B O. The janus-faced nature of prostasomes: their pluripotency favours the normal reproduc- tive process and malignant prostate growth[J]. Prostate Can- cer Prostatic Dis, 2004,7(1):21-31.
7SANTOS L L, MORAND E F. Macrophage migration inhibi tory factor: a key cytokine in RA, SLE and atherosclerosis[J]. Ctin Chim Acta, 2009,399(1/2) 1-7.
8LEAVER S K, MACCALLUM N S, PINGLE V, et al. In- creased plasma thioredoxin levels in patients with sepsis: posi tive association with macrophage migration inhibitory factor [J]. Intensive Care Med, 2010,36(2) :336-341.
9MITCHELL R A, IJAO H, CHESNEY J, et al. Macrophage mi- gration inhibitory factor (MIF) sustains macrophage proinflammato- ry function by inhibiting p53: regulatory role in the innate immune response[J]. Proc Natl Acad Sci U S A, 2002,99(1):345-350.
10MURAMAKI M, MIYAKE H, YAMADA Y, et al. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and di sease progression[J]. Oncol Rep, 2006,15(1) :253-257.
